You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞信窩輪》友邦續跌藥股回軟留意友邦購18879、石藥購21311
阿思達克 07-26 13:24

友邦保險(1299)周五跌勢未止,再跌逾1%,低位曾見84元,或需時整固才可再試高位。向上觀望重上10天線約86.3元的機會,支持參考82元水平。看好可留意友邦購20409,行使價98.05元,19年10月到期。或友邦牛50489,收回價82.38元,行使價81.78元,20年1月到期。相反看淡則可留意友邦沽20451,行使價79.95元,19年11月到期。或友邦熊57371,收回價89.89元,行使價90.49元,19年12月到期。

內險股中國平安(2318)周五變化不大,維持在95元附近整固。向上觀望挑戰98元的機會,支持留意92元水平。看好可留意平安購17533,行使價102.28元,19年10月到期。或平安牛50062,收回價92.18元,行使價91.58元,19年12月到期。相反看淡可留意平安沽29357,行使價84.38元,20年1月到期。或平安熊69987,收回價98.88元,行使價99.48元,20年1月到期。

內銀股招行(3968)公布半年業績快報後,周四急升,周五略見回軟,續守40元關口。看好可留意招行購28854,行使價42.68元,19年10月到期。或招行牛51372,收回價37.88元,行使價37.48元,20年5月到期。相反看淡可留意招行沽20488,行使價33.08元,20年1月到期。或招行熊57776,收回價43.88元,行使價44.28元,19年12月到期。

周四急升6%的醫藥股石藥集團(1093),周五回套逾2%,回落至14元水平以下。看好可考慮石藥購21311,行使價15.90元,20年3月到期。或石藥牛50767,收回價12.28元,行使價11.58元,20年7月到期。相反看淡可留意石藥熊65172,收回價14.18元,行使價14.88元,20年2月到期。

廣東省出台《豬十條》,同時亦關注下周中美貿易談判的進展,在美國有豬肉業務的食品股萬洲國際(0288),周五曾升逾4%,一度升穿8.5元,不過及後升幅收窄。看好可留意萬洲購19596,行使價8.89元,19年11月到期。

(本結構性產品並無抵押品)

《瑞信香港認股證及牛熊證銷售主管何啟聰》

免責聲明:筆者為瑞士信貸(香港)有限公司的代表 ,並身為證監會持牌人,並無持有相關上市公司的任何財務權益。本文內容僅供參考,並不構成要約、建議或促使任何人士提呈買賣或認購任何證券。結構性產品價格可急升或急跌,投資者或會蒙受全盤損失。本產品並無抵押品。如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。牛熊證備強制贖回機制而可能被提早終止,屆時(i)N類牛熊證投資者將不獲發任何金額;而(ii)R類牛熊證之剩餘價值可能為零。有關恆生指數或恆生中國企業指數的免責聲明,請參閱上市文件。過往表現並不反映將來表現。投資前,投資者應瞭解風險,並諮詢專業顧問及查閱有關上市文件。瑞信之聯屬公司為結構性產品之流通量提供者,亦可能是唯一報價者。本文任何內容概不構成投資、法律、會計或稅務意見、並無聲明任何投資或策略適合或符合閣下的個別情況。結構性產品交投量並不是結構性產品表現的指標,投資者不應僅依賴交投量歷史高位數據以釐定結構性產品日後的表現。~重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account